MERCK Kommanditgesellschaft auf Aktien MRK.DE Open MERCK Kommanditgesellschaft auf Aktien in new tab
MERCK Kommanditgesellschaft auf Aktien Analysis (MRK.DE)
Is MERCK Kommanditgesellschaft auf Aktien a good investment? MERCK Kommanditgesellschaft auf Aktien (MRK.DE) is currently trading at 119.95 EUR. Market analysts have a consensus price target of 141.40 EUR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 19.97. This valuation is generally in line with the broader market.
Earnings Schedule: MERCK Kommanditgesellschaft auf Aktien is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 8.59.
For income investors, MERCK Kommanditgesellschaft auf Aktien pays a dividend yield of 1.94%. With a payout ratio of 13%, the dividend appears sustainable.
Investor FAQ
Does MERCK Kommanditgesellschaft auf Aktien pay a dividend?
Yes, it pays an annual dividend of 2.20 EUR (1.94% yield).
What asset class is MERCK Kommanditgesellschaft auf Aktien?
MERCK Kommanditgesellschaft auf Aktien is classified as a Stock. You can compare it against 7 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 5.83.
Company Profile
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA is a subsidiary of E. Merck KG.
Dividend Yield
1.94% (5y avg: 1.16%)
Annual Dividends
2.20 EUR
Next ex. div date
April 27, 2026
Payout Ratio
12.65%
Historical Dividends
| Year | Total Dividends |
|---|---|
| 2027 | 2.64 EUR |
| April 27, 2027 (estimated) | 2.6382 |
| 2026 | 2.20 EUR |
| April 29, 2026 | 2.2000 |
| 2025 | 2.20 EUR |
| April 30, 2025 | 2.2000 |
| 2024 | 2.20 EUR |
| May 2, 2024 | 2.2000 |
| 2023 | 2.20 EUR |
| May 4, 2023 | 2.2000 |
| 2022 | 1.85 EUR |
| April 27, 2022 | 1.8500 |
| 2021 | 1.40 EUR |
| April 28, 2021 | 1.4000 |
| 2020 | 2.60 EUR |
| June 3, 2020 | 1.3000 |
| April 27, 2020 | 1.3000 |
| 2019 | 1.25 EUR |
| May 2, 2019 | 1.2500 |
| 2018 | 1.25 EUR |
| May 3, 2018 | 1.2500 |
| 2017 | 1.20 EUR |
| May 4, 2017 | 1.2000 |
| 2016 | 1.05 EUR |
| May 2, 2016 | 1.0500 |
| 2015 | 1.00 EUR |
| April 20, 2015 | 1.0000 |
| 2014 | 1.90 EUR |
| May 12, 2014 | 1.9000 |
| 2013 | 1.70 EUR |
| April 29, 2013 | 1.7000 |
| 2012 | 1.50 EUR |
| April 23, 2012 | 1.5000 |
| 2011 | 1.25 EUR |
| April 11, 2011 | 1.2500 |
| 2010 | 1.00 EUR |
| April 12, 2010 | 1.0000 |
| 2009 | 1.50 EUR |
| April 6, 2009 | 1.5000 |
| 2008 | 1.20 EUR |
| March 31, 2008 | 1.2000 |
| 2007 | 0.90 EUR |
| April 30, 2007 | 0.9000 |
| 2006 | 0.85 EUR |
| July 3, 2006 | 0.8500 |
| 2005 | 0.90 EUR |
| April 1, 2005 | 0.8000 |
| March 31, 2005 | 0.0985 |
| 2004 | 0.80 EUR |
| March 29, 2004 | 0.8000 |
| 2003 | 1.00 EUR |
| March 31, 2003 | 1.0000 |
| 2002 | 0.95 EUR |
| March 25, 2002 | 0.9500 |
| 2001 | 0.90 EUR |
| April 6, 2001 | 0.9000 |
| 2000 | 0.85 EUR |
| May 12, 2000 | 0.8500 |
Yearly aggregated dividends
Dividends
|
MERCK Kommanditgesellschaft auf Aktien
Apr 29, 2026 Paid
Dividend
2.2 EUR |
Historical Split Corporate Actions
| Split Date | Split Ratio to 1 |
|---|---|
| June 30, 2014 | 2.000000 |
| Jan. 24, 2007 | 1.010000 |
Explore Premium Features
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion